J Clin Aesthet Dermatol. 2020;13(5):12–18 by Dharm S. Patel, PhD; Karen A. Veverka, PhD; Jes B. Hansen, PhD; Paul S. Yamauchi, MD; Javier Alonso-Llamazares, MD; and Mark Lebwohl, MD Drs. Patel and Veverka are with LEO Pharma in Madison, New Jersey. Dr. Hansen is with LEO Pharma in Ballerup, Denmark. Dr. Yamauchi is with the
Background. Inverse psoriasis is characterized by erythematous nonscaly plaques in intertriginous regions. Similarly, erythrasma, a superficial infection caused by Corynebacterium minutissimum (C. minutissimum), is also found in skin folds with red-brown lesions, making the distinction between psoriasis and erythrasma difficult.
J Clin Aesthet Dermatol. 2020;13(2):22–29 by James Q. Del Rosso, DO, FAOCD, FAAD Dr. Del Rosso is with JDR Dermatology Research/Thomas Dermatology in Las Vegas, Nevada and Touro University Nevada in Henderson, Nevada. FUNDING: No funding was provided for this review. DISCLOSURES: Dr. Del Rosso has served as a consultant, speaker, and research investigator for
Innovations in Psoriasis Management Based on Selected Presentations from Music City SCALE Symposium for Cosmetic Advances & Laser Education May 9–11, 2019, Nashville, Tennessee by Jo Ann LeQuang Owner, LeQ Medical, Angleton, Texas; Director of Scientific Communications, NEMA Research, Inc., Naples, Florida; Founding Director, No Baby Blisters, Colorado Springs, Colorado. J Clin Aesthet Dermatol 2019;12(12):S8–S19 Based on
J Clin Aesthet Dermatol. 2019;12(12):28–34 by Corinna E. Psomadakis, MBBS, and George Han, MD Drs. Psomadakis and Han are with the Department of Dermatology, Mount Sinai Medical Center in New York, New York. FUNDING: No funding was provided for this study. DISCLOSURES: Dr. Han has consulted for Regeneron, Sanofi Genzyme, Pfizer, Sun, and Janssen. Dr.